Safety and effectiveness of a 300 IR house dust mite sublingual tablet: descriptive 4-year final analysis of a post-marketing surveillance in Japan

Early increase in serum specific IgG2 upon allergen immunotherapy with a 300 IR sublingual house dust mite tablet

(2023) Nathalie Berjont et al.   ALLERGY

The SQ HDM SLIT‐Tablet is safe and well tolerated in patients with House Dust Mite allergic rhinitis with or without asthma: A “real‐life” French study

(2022) Pascal Demoly et al.   Clinical and Translational Allergy

Executive summary: Japanese guidelines for allergic rhinitis 2020

(2022) Mitsuhiro Okano et al.   ALLERGOLOGY INTERNATIONAL

Coordinated IgG2 and IgE responses as a marker of allergen immunotherapy efficacy

(2021) Véronique Bordas‐Le Floch et al.   ALLERGY

Safety and effectiveness of the 300 IR sublingual house dust mite allergen immunotherapy tablet: 2-year interim analysis of a specified drug-use survey

(2021) Yoshitaka Okamoto et al.   Immunotherapy

Predictors for Short-Term Efficacy of Allergen-Specific Sublingual Immunotherapy in Children with Allergic Rhinitis

(2020) Wenlong Liu et al.   MEDIATORS OF INFLAMMATION

Japanese guidelines for allergic rhinitis 2020

(2020) Kimihiro Okubo et al.   ALLERGOLOGY INTERNATIONAL

A 300 IR sublingual tablet is an effective, safe treatment for house dust mite–induced allergic rhinitis: An international, double-blind, placebo-controlled, randomized phase III clinical trial

(2020) Pascal Demoly et al.   JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY

Mechanisms of allergen-specific immunotherapy and allergen tolerance

(2020) Umut C. Kucuksezer et al.   ALLERGOLOGY INTERNATIONAL

Allergic rhinitis

(2020) Jean Bousquet et al.   Nature Reviews Disease Primers

Adherence to treatment in allergic rhinitis using mobile technology. the mask study

(2019) E Menditto et al.   CLINICAL AND EXPERIMENTAL ALLERGY

EAACI Guidelines on Allergen Immunotherapy: House dust mite‐driven allergic asthma

(2019) Ioana Agache et al.   ALLERGY

Duration of allergen immunotherapy for inhalant allergy

(2019) Martin Penagos et al.   Current Opinion in Allergy and Clinical Immunology

Mechanisms of Subcutaneous and Sublingual Aeroallergen Immunotherapy

(2019) Zsolt István Komlósi et al.   IMMUNOLOGY AND ALLERGY CLINICS OF NORTH AMERICA

Treatment of allergic rhinitis using mobile technology with real-world data: The MASK observational pilot study

(2018) J. Bousquet et al.   ALLERGY

Real-world benefits of allergen immunotherapy for birch pollen-associated allergic rhinitis and asthma

(2018) Ulrich Wahn et al.   ALLERGY

Immunotherapy with grass pollen tablets reduces medication dispensing for allergic rhinitis and asthma: a retrospective database study in France

(2018) P. Devillier et al.   ALLERGY

Efficacy of house dust mite sublingual tablet in the treatment of allergic rhinoconjunctivitis: A randomized trial in a pediatric population

(2018) Yoshitaka Okamoto et al.   PEDIATRIC ALLERGY AND IMMUNOLOGY

Allergic Rhinitis and its Impact on Asthma (ARIA) guidelines—2016 revision

(2017) Jan L. Brożek et al.   JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY

Mechanisms of allergen immunotherapy for inhaled allergens and predictive biomarkers

(2017) Mohamed H. Shamji et al.   JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY

House dust mite sublingual tablet is effective and safe in patients with allergic rhinitis

(2016) Y. Okamoto et al.   ALLERGY

Clinical contraindications to allergen immunotherapy: an EAACI position paper

(2015) C. Pitsios et al.   ALLERGY

MACVIA-ARIA Sentinel NetworK for allergic rhinitis (MASK-rhinitis): the new generation guideline implementation

(2015) J. Bousquet et al.   ALLERGY

Timothy specific IgE levels are associated with efficacy and safety of timothy grass sublingual immunotherapy tablet

(2015) Maria Nolte et al.   ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY

Respiratory allergy caused by house dust mites: What do we really know?

(2015) Moisés A. Calderón et al.   JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY

Efficacy and safety of sublingual tablets of house dust mite allergen extracts in adults with allergic rhinitis

(2014) Karl-Christian Bergmann et al.   JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY

Japanese Guideline for Allergic Rhinitis 2014

(2014) Kimihiro Okubo et al.   ALLERGOLOGY INTERNATIONAL

Clinical efficacy of 300IR 5-grass pollen sublingual tablet in a US study: The importance of allergen-specific serum IgE

(2012) Linda S. Cox et al.   JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY